113 related articles for article (PubMed ID: 27908660)
1. Targeting of multiple senescence-promoting genes and signaling pathways by triptonide induces complete senescence of acute myeloid leukemia cells.
Pan Y; Meng M; Zheng N; Cao Z; Yang P; Xi X; Zhou Q
Biochem Pharmacol; 2017 Feb; 126():34-50. PubMed ID: 27908660
[TBL] [Abstract][Full Text] [Related]
2. Triptonide acts as a novel potent anti-lymphoma agent with low toxicity mainly through inhibition of proto-oncogene Lyn transcription and suppression of Lyn signal pathway.
Yang P; Dong F; Zhou Q
Toxicol Lett; 2017 Aug; 278():9-17. PubMed ID: 28666825
[TBL] [Abstract][Full Text] [Related]
3. Triptonide effectively suppresses gastric tumor growth and metastasis through inhibition of the oncogenic Notch1 and NF-κB signaling pathways.
Xiang S; Zhao Z; Zhang T; Zhang B; Meng M; Cao Z; Zhou Q
Toxicol Appl Pharmacol; 2020 Feb; 388():114870. PubMed ID: 31866380
[TBL] [Abstract][Full Text] [Related]
4. Identification of triptonide as a therapeutic agent for triple negative breast cancer treatment.
Gao B; Chen J; Han B; Zhang X; Hao J; Giuliano AE; Cui Y; Cui X
Sci Rep; 2021 Jan; 11(1):2408. PubMed ID: 33510281
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of tumor-suppressive MAPKP signaling pathway by triptonide effectively inhibits pancreatic cancer cell tumorigenicity and tumor growth.
Zhang B; Meng M; Xiang S; Cao Z; Xu X; Zhao Z; Zhang T; Chen B; Yang P; Li Y; Zhou Q
Biochem Pharmacol; 2019 Aug; 166():70-81. PubMed ID: 31075266
[TBL] [Abstract][Full Text] [Related]
6. Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway.
Zhang M; Tan S; Yu D; Zhao Z; Zhang B; Zhang P; Lv C; Zhou Q; Cao Z
Toxicol Appl Pharmacol; 2019 Feb; 365():1-8. PubMed ID: 30610878
[TBL] [Abstract][Full Text] [Related]
7. Triptonide acts as a novel antiprostate cancer agent mainly through inhibition of mTOR signaling pathway.
Dong F; Yang P; Wang R; Sun W; Zhang Y; Wang A; Chen M; Chen L; Zhang C; Jiang M
Prostate; 2019 Aug; 79(11):1284-1293. PubMed ID: 31212374
[TBL] [Abstract][Full Text] [Related]
8. Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts.
Wang Z; Ma D; Wang C; Zhu Z; Yang Y; Zeng F; Yuan J; Liu X; Gao Y; Chen Y; Jia Y
Biomed Pharmacother; 2017 Dec; 96():757-767. PubMed ID: 29049979
[TBL] [Abstract][Full Text] [Related]
9. [Diterpene constituents of Tripterygium willfordii (II)].
Lin S; Que HQ; Peng HY; Qian LP; Guo SM; Li YC
Yao Xue Xue Bao; 2011 Aug; 46(8):942-5. PubMed ID: 22007519
[TBL] [Abstract][Full Text] [Related]
10. Triptonide inhibits human nasopharyngeal carcinoma cell growth via disrupting Lnc-RNA THOR-IGF2BP1 signaling.
Wang SS; Lv Y; Xu XC; Zuo Y; Song Y; Wu GP; Lu PH; Zhang ZQ; Chen MB
Cancer Lett; 2019 Feb; 443():13-24. PubMed ID: 30503558
[TBL] [Abstract][Full Text] [Related]
11. Corchorusin-D, a saikosaponin-like compound isolated from Corchorus acutangulus Lam., targets mitochondrial apoptotic pathways in leukemic cell lines (HL-60 and U937).
Mallick S; Ghosh P; Samanta SK; Kinra S; Pal BC; Gomes A; Vedasiromoni JR
Cancer Chemother Pharmacol; 2010 Sep; 66(4):709-19. PubMed ID: 20033811
[TBL] [Abstract][Full Text] [Related]
12. Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins.
Zhang M; Meng M; Liu Y; Qi J; Zhao Z; Qiao Y; Hu Y; Lu W; Zhou Z; Xu P; Zhou Q
Breast Cancer Res; 2021 Dec; 23(1):116. PubMed ID: 34922602
[TBL] [Abstract][Full Text] [Related]
13. Activation of the tumor suppressive Hippo pathway by triptonide as a new strategy to potently inhibit aggressive melanoma cell metastasis.
Tan S; Zhao Z; Qiao Y; Zhang B; Zhang T; Zhang M; Qi J; Wang X; Meng M; Zhou Q
Biochem Pharmacol; 2021 Mar; 185():114423. PubMed ID: 33476574
[TBL] [Abstract][Full Text] [Related]
14. Synergistic cooperation between ABT-263 and MEK1/2 inhibitor: effect on apoptosis and proliferation of acute myeloid leukemia cells.
Airiau K; Prouzet-Mauléon V; Rousseau B; Pigneux A; Jeanneteau M; Giraudon M; Allou K; Dubus P; Belloc F; Mahon FX
Oncotarget; 2016 Jan; 7(1):845-59. PubMed ID: 26625317
[TBL] [Abstract][Full Text] [Related]
15. Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.
Han H; Du L; Cao Z; Zhang B; Zhou Q
Eur J Pharmacol; 2018 Jan; 818():593-603. PubMed ID: 29162433
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic biotransformed products from triptonide by Aspergillus niger.
Ning L; Qu G; Ye M; Guo H; Bi K; Guo D
Planta Med; 2003 Sep; 69(9):804-8. PubMed ID: 14598204
[TBL] [Abstract][Full Text] [Related]
17. A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.
Huang MJ; Cheng YC; Liu CR; Lin S; Liu HE
Exp Hematol; 2006 Nov; 34(11):1480-9. PubMed ID: 17046567
[TBL] [Abstract][Full Text] [Related]
18. Triptolide inhibits cell proliferation and tumorigenicity of human neuroblastoma cells.
Yan X; Ke XX; Zhao H; Huang M; Hu R; Cui H
Mol Med Rep; 2015 Feb; 11(2):791-6. PubMed ID: 25354591
[TBL] [Abstract][Full Text] [Related]
19. Quercetin induces mitochondrial-derived apoptosis via reactive oxygen species-mediated ERK activation in HL-60 leukemia cells and xenograft.
Lee WJ; Hsiao M; Chang JL; Yang SF; Tseng TH; Cheng CW; Chow JM; Lin KH; Lin YW; Liu CC; Lee LM; Chien MH
Arch Toxicol; 2015 Jul; 89(7):1103-17. PubMed ID: 25138434
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
